Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Interstitial Cystitis

ClinicalTrials.gov ID: NCT00056251

Public ClinicalTrials.gov record NCT00056251. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 1:14 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of RTX Topical Solution in Patients With Interstitial Cystitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Patients with interstitial cystitis who meet eligibility requirements will be randomized to one of four treatment arms (3 RTX, Placebo). Study drug is administered as a single instillation within the urinary bladder. Study duration is 12 weeks.

Study identification

NCT ID
NCT00056251
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
ICOS Corporation
Industry
Enrollment
150 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2002
Primary completion
Not listed
Completion
Jul 31, 2003
Last update posted
Jun 23, 2005

2003

United States locations

U.S. sites
24
U.S. states
19
U.S. cities
23
Facility City State ZIP Site status
Alaska Clinical Research Center Anchorage Alaska
Citrus Valley Medical Research, Inc. Glendora California
Center for Urological Research La Mesa California
Atlantic Urological Medical Group Long Beach California
Stanford University Medical Center Stanford California
Colorado Gynecology & Continence Center Denver Colorado
dba Genitourinary Surgical Consultants, PC Denver Colorado
The Connecticut Clinical Research Center-Urology Specialist Waterbury Connecticut
Advanced Research Institute New Port Richey Florida
Georgia Urology Atlanta Georgia
Northeast Indiana Research, LLC Fort Wayne Indiana
Urology of Indiana, LLC Indianapolis Indiana
KU Medical Center Research Institute Kansas City Kansas
University of Maryland Baltimore Maryland
Michigan William Beaumont Hospital Royal Oak Michigan
St. Louis Urological Surgeons St Louis Missouri
Michael Kaplan, MD, Ltd. Henderson Nevada
The Urology Center Greensboro North Carolina
Urologic Specialists of Oklahoma Tulsa Oklahoma
Oregon Urology Specialists Eugene Oregon
Pennsylvania Graduate Hospital Philadelphia Pennsylvania
Vanderbilt University Medical Center Nashville Tennessee
Urology San Antonio San Antonio Texas
Integrity Medical Research, LLC Seattle Washington

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00056251, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 23, 2005 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00056251 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →